For over two decades, a ‘treatment-risk paradox’ has been described in older adults with cardiovascular disease, with ...

Patients were eligible if they had ST elevation myocardial infarction (STEMI) or large non-ST elevation myocardial infarction ...

For patients with either NSTEMI or STEMI, American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend that intravenous unfractionated heparin (UFH) be dosed by weight ...

Following cardiac catheterization, patients with ST-segment elevation myocardial infarction (STEMI) have a higher risk of short-term mortality than patients with non-STEMI (NSTEMI), who have a ...

Individual patient data were obtained from three trials, including 9130 randomized patients with ACS: 3132 with ST-segment elevation myocardial infarction (STEMI); 3023 with non-STEMI (NSTEMI ...

For patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation, de-escalating dual antiplatelet therapy (DAPT) to P2Y12 inhibitor monotherapy is associated with lower ...